This late-stage clinical trial company focuses on preventing inflammation and acute organ injury. It is developing a platform of new drugs to prevent inflammation in the kidneys, liver and lungs...

To read the full story on AllPennyStocks.com, click here.

Arch Biopartners (TSXV:ARCH)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas Arch Biopartners.
Arch Biopartners (TSXV:ARCH)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas Arch Biopartners.